Welcome to our dedicated page for Ayr Wellness news (Ticker: AYRWF), a resource for investors and traders seeking the latest updates and insights on Ayr Wellness stock.
AYR Wellness Inc. (AYRWF) is a vertically integrated cannabis operator with multi-state retail dispensaries and proprietary cannabis products. This page serves as the definitive source for official company announcements and market-relevant developments.
Investors and industry observers will find curated press releases covering regulatory milestones, earnings reports, and retail expansions. Our aggregation ensures efficient tracking of operational updates across AYR's cultivation, manufacturing, and distribution networks.
Content spans licensing achievements, product portfolio enhancements, and compliance initiatives critical to understanding this cannabis operator's positioning. Bookmark this resource for streamlined monitoring of AYR's progress in evolving markets.
AYR Wellness (OTCQX: AYRWF) announced it has initiated CCAA proceedings in British Columbia as part of a court‑supervised restructuring under a Restructuring Support Agreement dated July 30, 2025. Core subsidiary assets will be transferred to a newly formed acquisition vehicle (NewCo) owned by certain senior noteholders, subject to regulatory approvals and closing conditions.
The company will seek a licensed insolvency trustee as monitor, the corporate parent will be wound down, Blake Holzgrafe is named Interim CEO of the corporate parent, and Davido is expected to become Interim CEO of NewCo.
AYR Wellness (OTCQX: AYRWF) announced that a public Article 9 foreclosure auction held on November 10, 2025 resulted in a successful credit bid by the company’s senior noteholders to acquire core collateral assets and subsidiary equity in FL, NJ, NV, OH, MA, PA, and VA.
The company expects to sign a Master Purchase Agreement (MPA), seek regulatory approvals to transfer licenses to a newly formed acquisition vehicle (NewCo), and commence CCAA proceedings in British Columbia to wind down the existing corporate parent.
AYR Wellness (OTCQX: AYRWF) opened its first indoor cultivation facility in Ocala, Florida on Oct. 14, 2025, a 97,580 sq. ft. site with nearly 50,000 sq. ft. of grow canopy. The facility debuts Kynd brand indoor flower including Purple Alien, Powdered Doughnuts, and Tiger Bomb and will supply AYR dispensaries statewide for registered medical patients.
AYR expects the site to employ approximately 100 team members across cultivation, operations, and technical roles and says the facility uses advanced LED lighting, sustainable irrigation, and aims for consistent harvests while conserving water.
AYR Wellness (OTCQX: AYRWF) announced commencement of Article 9 restructuring proceedings under its Restructuring Support Agreement dated July 30, 2025.
The company said Odyssey Trust, as collateral trustee, has notified disposition of collateral and launched a public foreclosure sale of certain subsidiaries’ assets across Florida, New Jersey, Nevada, Ohio, Massachusetts, and Pennsylvania. A public auction is scheduled for November 10, 2025 at 10:00 a.m. ET at Paul Hastings in New York and/or virtually. AYR said it will continue operating the businesses during the process and is cooperating with senior noteholders; qualified bidders must follow bid procedures.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has announced the filing of its unaudited interim financial statements and Management's Discussion and Analysis (MD&A) for Q1 2025. The documents are now available on SEDAR+ and SEC's EDGAR system.
The company provided definitions of non-GAAP measures used in their reporting, including "Adjusted EBITDA" and "Adjusted Gross Profit". These metrics are used to evaluate business performance and capital structure, offering investors additional perspectives on operational decision-making.
AYR Wellness (OTCQX: AYRWF) has executed a definitive senior secured bridge term loan agreement providing up to $50 million in committed funding. The Bridge Facility, secured through CSAC Holdings Inc., will support ongoing operations and facilitate business transition under the July 30, 2025 restructuring support agreement (RSA).
The facility includes multiple draws with 14% per annum interest rate payable in kind, featuring Initial Term Loans (Tranche A and B) and Delayed Draw Term Loans. Key premiums include 10% commitment premium, 10% exit premium, and 15% backstop premium. The facility requires maintaining minimum liquidity of $17.5 million and will automatically convert into a senior secured "take-back" term facility upon completion of the planned Article 9 sale transaction.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has entered into a Restructuring Support Agreement (RSA) with senior noteholders to restructure its debt and transition ownership. The agreement includes:
The deal features a $50 million Bridge Facility at 14% interest rate, an Article 9 sale process for assets in six states (Florida, Ohio, Nevada, New Jersey, Pennsylvania, and Virginia), and conversion of senior notes into 100% equity in the new company (NewCo). The restructuring involves asset sales, debt restructuring, and potential liquidation of remaining assets through Companies' Creditors Arrangement Act proceedings.
Senior noteholders will receive pro-rata shares of NewCo equity in exchange for canceling credit bid portion of notes, while remaining note balances will be entitled to proceeds from remaining asset liquidation.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 29, 2025.
The waiver covers defaults related to delayed Q1 2025 financial statements and certain payment defaults under other outstanding debt. While temporary, this agreement prevents noteholders from exercising default-related rights during the waiver period. The company continues normal operations while evaluating growth opportunities in key markets.
AYR Wellness (OTCQX: AYRWF) has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 25, 2025. The extension maintains the temporary waiver of certain defaults related to delayed Q1 2025 financial filings and potential payment defaults on other outstanding debt.
This agreement prevents senior noteholders from exercising default-related rights while providing AYR additional time to negotiate with senior lenders and explore strategic options to strengthen its capital structure. The company continues to operate normally while evaluating growth opportunities in key markets.
AYR Wellness (OTCQX: AYRWF) has secured an extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 18, 2025. The waiver addresses defaults related to delayed Q1 2025 financial filings and certain payment defaults on outstanding debt.
The temporary waiver prevents noteholders from exercising default-related rights while the company continues negotiations with senior lenders and explores strategic options to strengthen its capital structure. AYR continues to operate normally and evaluate growth opportunities while working with stakeholders to address its financial obligations.